These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27116463)

  • 1. Oral versus transdermal estrogens and venous thromboembolism in postmenopausal women: what is new since 2003?
    Canonico M; Scarabin PY
    Menopause; 2016 Jun; 23(6):587-8. PubMed ID: 27116463
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M; Scarabin PY
    Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
    Scarabin PY
    Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
    Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
    Menopause; 2018 Nov; 25(11):1297-1305. PubMed ID: 30358726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
    Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
    Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
    Olié V; Canonico M; Scarabin PY
    Curr Opin Hematol; 2010 Sep; 17(5):457-63. PubMed ID: 20601871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
    Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
    Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 17. In postmenopausal women, oral but not transdermal estrogen was associated with increased risk for stroke.
    Ott SM
    Ann Intern Med; 2016 Oct; 165(8):JC46. PubMed ID: 27750306
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review.
    Goldštajn MŠ; Mikuš M; Ferrari FA; Bosco M; Uccella S; Noventa M; Török P; Terzic S; Laganà AS; Garzon S
    Arch Gynecol Obstet; 2023 Jun; 307(6):1727-1745. PubMed ID: 35713694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
    Kaunitz AM
    Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.